Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Mar;73(3):847–851. doi: 10.1073/pnas.73.3.847

Sex differences in binding of human growth hormone to isolated rat hepatocytes.

M B Ranke, C A Stanley, D Rodbard, L Baker, A Bongiovanni, J S Parks
PMCID: PMC336016  PMID: 176658

Abstract

Since liver is a target for growth hormone action, binding of 125I-labeled human growth hormone to enzymatically isolated rat hepatocytes was studied. Specific binding was shown with hepatocytes from both male and female animals. There was a single class of receptors for human growth hormone on cells from males (affinity constant, Ka = 1.16 x 10(9) liters/mole; sites per cell, q = 6200). In males, bovine growth hormone was almost as potent as human growth hormone in displacing bound 125I-labeled human growth hormone, while ovine prolactin was about 1000 times less potent. Cells from female rats bound more 125I-labeled human growth hormone than cells from males. The cells from females contained at least two classes of receptors for human growth hormone. The receptor of highest affinity had the same affinity for human growth hormone as the single receptor found in males (Ka = 0.96 x 10(9) liters/mole). However, there were three to four times as many of these receptors per cell in females (q = 21,000). In females, bovine growth hormone and ovine prolactin were both about 20 times less potent than human growth hormone. Treatment of male rats with estrone produced cells that show the same binding characteristics as females. These results indicate that human growth hormone binds to a somatogenic receptor in hepatocytes from male rats. In females and estrogen-treated males, the receptors that bind human growth hormone recognize lactogenic as well as somatogenic properties. This suggests that the lactogenic and growth-promoting effects of human growth hormone in the rat are mediated by different receptors.

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry M. N., Friend D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969 Dec;43(3):506–520. doi: 10.1083/jcb.43.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gavin J. R., 3rd, Gorden P., Roth J., Archer J. A., Buell D. N. Characteristics of the human lymphocyte insulin receptor. J Biol Chem. 1973 Mar 25;248(6):2202–2207. [PubMed] [Google Scholar]
  3. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  4. Kelly P. A., Posner B. I., Tsushima T., Friesen H. G. Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy. Endocrinology. 1974 Aug;95(2):532–539. doi: 10.1210/endo-95-2-532. [DOI] [PubMed] [Google Scholar]
  5. Kleinberg D. L., Frantz A. G. Human prolactin: measurement in plasma by in vitro bioassay. J Clin Invest. 1971 Aug;50(8):1557–1568. doi: 10.1172/JCI106643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lesniak M. A., Gorden P., Roth J., Gavin J. R., 3rd Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay. J Biol Chem. 1974 Mar 25;249(6):1661–1667. [PubMed] [Google Scholar]
  7. Mayberry H. E., Van den Brande J. L., Van Wyk J. J., Waddell W. J. Early localization of 125-I-labelled human growth hormone in adrenals and other organs of immature hypophysectomized rats. Endocrinology. 1971 Jun;88(6):1309–1317. doi: 10.1210/endo-88-6-1309. [DOI] [PubMed] [Google Scholar]
  8. McConaghey P., Dehnel J. Preliminary studies of 'sulphation factor' production by rat kidney. J Endocrinol. 1972 Mar;52(3):587–588. doi: 10.1677/joe.0.0520587. [DOI] [PubMed] [Google Scholar]
  9. McConaghey P., Sledge C. B. Production of "sulphation factor" by the perfused liver. Nature. 1970 Mar 28;225(5239):1249–1250. doi: 10.1038/2251249b0. [DOI] [PubMed] [Google Scholar]
  10. Posner B. I., Kelly P. A., Friesen H. G. Induction of a lactogenic receptor in rat liver: influence of estrogen and the pituitary. Proc Natl Acad Sci U S A. 1974 Jun;71(6):2407–2410. doi: 10.1073/pnas.71.6.2407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Posner B. I., Kelly P. A., Shiu R. P., Friesen H. G. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology. 1974 Aug;95(2):521–531. doi: 10.1210/endo-95-2-521. [DOI] [PubMed] [Google Scholar]
  12. Tsushima T., Friesen H. G. Radioreceptor assay for growth hormone. J Clin Endocrinol Metab. 1973 Aug;37(2):334–337. doi: 10.1210/jcem-37-2-334. [DOI] [PubMed] [Google Scholar]
  13. Van Wyk J. J., Underwood L. E., Hintz R. L., Clemmons D. R., Voina S. J., Weaver R. P. The somatomedins: a family of insulinlike hormones under growth hormone control. Recent Prog Horm Res. 1974;30(0):259–318. [PubMed] [Google Scholar]
  14. de Meyts P., Roth J., Neville D. M., Jr, Gavin J. R., 3rd, Lesniak M. A. Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun. 1973 Nov 1;55(1):154–161. doi: 10.1016/s0006-291x(73)80072-5. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES